IPP Bureau
AstraZeneca Pharma India appoints Vinay Sharma as Business Unit Head - Rare Disease
By IPP Bureau - March 26, 2024
Currently, Sharma is a part of the Philippines Country Leadership Team as Business Unit Head Respiratory & Immunology
AstraZeneca’s FLAURA2 Phase III trial showed favourable trend in EGFR-mutated advanced lung cancer
By IPP Bureau - March 23, 2024
Combination shows consistent benefit across prespecified post-progression outcomes
Briefs: Concord Biotech and Neuland Laboratories
By IPP Bureau - March 23, 2024
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Sharon Bio-Medicine resumes operations
By IPP Bureau - March 23, 2024
Operations of Line II was stopped due to a fire incident earlier
'Illness To Wellness’ joins hands with ILBS to generate awareness against Hepatitis B patients
By IPP Bureau - March 23, 2024
Hepatitis B infects over 40 million people in India
USFDA grants ODD to Cevidoplenib for immune thrombocytopenia
By IPP Bureau - March 23, 2024
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Dr. Reddy's and Pharmazz inks agreement to market Centhaquine for hypovolemic shock in India
By IPP Bureau - March 23, 2024
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Zydus receives tentative approval from USFDA for Letermovir Tablets
By IPP Bureau - March 23, 2024
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
Akums introduces Hydroxyurea oral suspension for sickle cell disease
By IPP Bureau - March 22, 2024
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Merck invests € 300 million in new Life Science production site in South Korea
By IPP Bureau - March 21, 2024
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
By IPP Bureau - March 21, 2024
Pharma Solutions operates 10 research and development and/or production sites globally
dsm-firmenich launches food and beverages pilot plant in US
By IPP Bureau - March 21, 2024
The pilot plant is focused on scaling up beverage production and will support applications
Johnson Matthey sells Medical Device Components business for US$700 million to Montagu
By IPP Bureau - March 21, 2024
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Bristol Myers Squibb completes acquisition of Karuna Therapeutics
By IPP Bureau - March 21, 2024
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
